SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001140361-19-018091
Filing Date
2019-10-07
Accepted
2019-10-07 19:40:39
Documents
1
Period of Report
2019-10-07

Document Format Files

Seq Description Document Type Size
1 FORM 4 form4.html 4  
1 FORM 4 form4.xml 4 15732
  Complete submission text file 0001140361-19-018091.txt   18451
Mailing Address ONE SANSOME, SUITE 3630 SAN FRANCISCO CA 94104
Business Address ONE SANSOME, SUITE 3630 SAN FRANCISCO CA 94104 (415) 801-8100
Versant Vantage I, L.P. (Reporting) CIK: 0001765253 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-39069 | Film No.: 191141698

Mailing Address ONE SANSOME STREET, SUITE 3630 SAN FRANCISCO CA 94104
Business Address ONE SANSOME STREET, SUITE 3630 SAN FRANCISCO CA 94104 415-801-8100
Versant Vantage I GP, L.P. (Reporting) CIK: 0001777651 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-39069 | Film No.: 191141699

Mailing Address ONE SANSOME STREET, SUITE 3630 SAN FRANCISCO CA 94104
Business Address ONE SANSOME STREET, SUITE 3630 SAN FRANCISCO CA 94104 415-801-8100
Versant Vantage I GP-GP, LLC (Reporting) CIK: 0001777653 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-39069 | Film No.: 191141700

Mailing Address 535 BOYLSTON STREET BOSTON MA 02116
Business Address 535 BOYLSTON STREET BOSTON MA 02116 6095104718
Aprea Therapeutics, Inc. (Issuer) CIK: 0001781983 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences